EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Chronic expanding hematoma involving the pectoralis major muscle years after breast implant removal: a case report

Hyung Hwa Jeong, Young Hun Kang, Sung Woon Kim, Chang Yong Choi, Han Gyu Cha, Eun Soo Park

Archives of Aesthetic Plastic Surgery · 2026-10-30 · 32 (4) · 104-109

DOI: 10.14730/aaps.2026.01767 ↗
AbstractBibliografische Angaben

Abstract

Late hematoma is a rare complication of implant-based breast augmentation and has seldom been reported after implant removal. We describe a 36-year-old woman with a hard, fixed, painless mass at the left inframammary fold that had slowly enlarged over 3 years. She had undergone bilateral augmentation mammoplasty 10 years earlier and implant removal 7 years earlier. Magnetic resonance imaging showed a 9-cm lobulated, rim-enhancing lesion comprising a 7-cm retropectoral cystic component connected to a 3-cm septated component in the lower lateral chest wall. The lesion showed early rapid enhancement with delayed washout on kinetic analysis but a persistent pattern on reverse subtraction images. Ultrasonography suggested a granuloma associated with retained implant material. Exploration through an inframammary fold incision revealed dark red old blood and clots without a solid tumor component, and the hematoma was evacuated. Recovery was uneventful, with no complications reported during 2 months of follow-up. Chronic expanding hematoma should be considered when evaluating a slowly growing mass in a former implant pocket, even years after explantation, because its imaging features may mimic retained silicone, implant-associated lymphoma, or soft tissue sarcoma.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →